RTI-1092663

N/A

Report date: 2025/01/26 15:39:06
NME

Base Information

Drug NameRTI-1092663
Drug Alias Namecannabinoid receptor 1 inverse agonists (RTI International)RTI-1092663
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor inverse agonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsMetabolic Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRti International
China Registration ClassN/A

Develop Information

Active CompaniesRti International
Inactive CompaniesN/A
Active IndicationsMetabolic Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A